| |
CD10 Negative
(n=38) |
CD10 Positive
(n=47) |
p Value |
| Tumor size (groups) |
|
|
|
• Below 5 cm
|
21 (55.3%) |
08 (17%) |
p<0.0001 |
• 5 to 10 cm
|
13 (34.2%) |
17 (36.2%) |
|
• Above 10 cm
|
04 (10.5%) |
22 (46.8%) |
|
| Stromal Atypia |
• Mild
|
25 (65.8%) |
10 (21.3%) |
p<0.0001 |
• Moderate
|
05 (13.2%) |
14 (56%) |
|
• Marked
|
08 (21.1%) |
23 (8%) |
|
| Stromal cellularity |
• Mild
|
18 (47.4%) |
05 (10.6%) |
p<0.0001 |
• Moderate
|
13 (34.2 %) |
17 (36.2%) |
|
• Marked
|
07 (18.4%) |
25 (53.2%) |
|
| Tumor margins |
• Pushing
|
31 (81.6%) |
20 (42.6%) |
p<0.0001 |
• Infiltrative
|
07 (18.4%) |
27 (57.4%) |
|
| Mitotic count |
• 0-4 / 10HPF
|
23 (60.5%) |
05 (10.6%) |
p<0.0001 |
• 5-9 / 10HPF
• >10 /10HPF
|
07 (18.4%)
08 (21.1%) |
14 (29.8%)
28 (59.6%) |
| Necrosis |
• Present
|
01 (2.6%) |
05 (10.6%) |
p =0.218 |
• Absent
|
37 (97.4%) |
42 (89.4%) |
| Sarcomatouscomponent |
00 |
02 (4.3%) |
p =0.500 |
|
